Trending
August 14, 2024

Galera Announces Board Approval of Complete Liquidation and Dissolution

August 14, 2024

Verrica Pharmaceuticals Reports Second Quarter 2024 Financial Results

August 13, 2024

Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial Results

August 13, 2024

Virpax Pharmaceuticals Reports 2024 Second Quarter Results and Recent Developments

August 13, 2024

NRx Pharmaceuticals Announces Up to $16 Million Senior Secured Debt Financing from Anson Funds

August 12, 2024

NEXGEL Announces $1,110,000 Registered Direct Offering

August 12, 2024

Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates

August 9, 2024

Soligenix Announces Recent Accomplishments And Second Quarter 2024 Financial Results

August 9, 2024

Amneal Reports Second Quarter 2024 Financial Results

August 9, 2024

Merck to Acquire Investigational B-Cell Depletion Therapy, CN201, from Curon Biopharmaceutical

August 8, 2024

Carisma Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

August 8, 2024

Insmed Reports Second-Quarter 2024 Financial Results and Provides Business Update

August 7, 2024

Chromocell Announces Stock Repurchase Plan

August 7, 2024

Aclaris Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

August 7, 2024

Philadelphia Places Fifth in Ranking of Biopharma Clusters

August 6, 2024

Melinta Therapeutics Appoints Fabrizio Tondolo, MD, as Vice President of Medical Affairs